LLS Patient Education: Novel Therapeutic Options for Lymphoma, An Evening with Experts from Weill Cornell

Novel Therapeutic Options for Lymphoma:
What Every Patient Needs to Know about Ibrutinib, Idelalisib, and Other New Drug

The Leukemia & Lymphoma Society (LLS) in partnership with Weill Cornell Medical College and NewYork-Presbyterian Weill Cornell Medical Center are presenting a patient education event on Wednesday, April 30 at Weill Cornell Medical College.

Click here to register or contact Trisha Ouellette at (212) 376-4762.


  • General overview of lymphoma
  • Clinical Trials/Select New Therapies
  • Complementary Medicine
  • Panel Discussion/Q&A


John Leonard, MD


Richard Furman, MD
Peter Martin, MD
Jia Ruan, MD

Date and Time:

Wednesday, April 30, 2014 5:30pm-8pm


The Griffis Faculty Club at Weill Cornell Medical College
521 East 68th Street (east of York Avenue)
New York, NY 10021

A light dinner will be provided

More information can be found here

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: